Bioactive Compounds
-
B7170 U 93631Summary: GABAA receptor antagonist -
B5091 RS 100329 hydrochlorideSummary: Subtype-selective α1A-adrenoceptor antagonist -
SL1071 Retigabine-d4Summary: A stable isotope deuterated compound of Retigabine -
C4252 ML115Summary: A selective STAT3 agonist for research on cell proliferation and differentiation. -
BA9382 Boc-His-OMeSummary: A histidine derivative. -
A9938 3-Phosphoglyceric acidSummary: Metabolic intermediates of glycolysis and Calvin cycle -
A8101 Cy3.5 NHS ester (non-sulfonated)Summary: Cy3.5 NHS ester (non-sulfonated), labels primary amines, emission (~604 nm) longer than Cy3. -
C3205 LanicemineSummary: voltage-dependent NMDA channel blocker -
C5074 N-acetyl-2-carboxy BenzenesulfonamideSummary: non-selective inhibitor of COX -
B5541 PIR 3.5Summary: A PAK1 serine/threonine kinase inhibitor

